ENTITY
Pharmaessentia Corp

Pharmaessentia Corp (6446 TT)

83
Analysis
Health Care • Taiwan
PharmaEssentia Corporation develops and distributes therapeutic products for treatment in human disease. The Company develops drugs to treat hepatitis, chronic myeloid leukemia (CML), essential thrombocythemia (ET), myeloid fibrosis (MF), polycythemia vera (PV), hepatitis and cancer.
more
bearish•Quantitative Analysis
•05 Aug 2024 07:05

TWSE Foreign Holding Weekly (Aug 2nd): Umc, TSMC, Hon Hai, Mediatek, Quanta Computer, Unimicron Tech

We analyzed TWSE foreign holding data for the past week and highlighted foreign holding changes in Umc, TSMC, Hon Hai, Mediatek, Quanta Computer,...

Logo
253 Views
Share
•27 Jul 2024 04:59

Pullback Underway; Getting Defensive; Long-Term RS Bottoms for Defensives Is a Reason for Caution

Pullback Underway $ACWI $SPX; Getting Defensive; Long-Term RS Bottoms for Defensive Sectors is a Reason for Caution. Buys in Health Care,...

Logo
522 Views
Share
bullish•Quantitative Analysis
•22 Jul 2024 07:05

TWSE Foreign Holding Weekly (Jul 19th): Wiwynn, TSMC, Quanta Computer, Mediatek, Gigabyte Tech

We analyzed TWSE foreign holding data for the past week and highlighted foreign holding changes in Wiwynn, TSMC, Quanta Computer, Mediatek,...

Logo
295 Views
Share
bullish•Pharmaessentia Corp
•25 Jun 2024 22:32

Pharmaessentia Corp (6446 TT): Starts 2024 on Strong Note; Reports First Operating Profit in 1Q24

​Pharmaessentia reports strong 1Q24 results with increased revenue, decreased operating expenses, and first-time operating profit. Geography and...

Logo
362 Views
Share
bearish•Quantitative Analysis
•10 Jun 2024 07:05

TWSE Foreign Holding Weekly (Jun 7th): Realtek Semi, Asmedia Tech, Global Unichip, Yang Ming Marine

We analyzed TWSE foreign holding data for the past week and highlighted foreign holding changes in Realtek Semi, Asmedia Tech, Global Unichip, Yang...

Logo
427 Views
Share
x